Safety, Tolerability, and Pharmacokinetics After a Single Dose of Orally Inhaled DNAzyme Solution for Nebulisation in Male Patients With Asthma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Sterna Biologicals GmbH & Co. KG
ClinicalTrials.gov Identifier:
NCT01577953
First received: April 11, 2012
Last updated: November 21, 2012
Last verified: November 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2012
  Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)